Addex Therapeutics Ltd
XMUN:APE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Addex Therapeutics Ltd
XMUN:APE
|
CH |
Intrinsic Value
The intrinsic value of 
Addex Therapeutics Ltd (APE) under the Base Case is 0.675 EUR per share.
Compared with the current market price of 2.196 EUR, the stock appears
Overvalued by 69% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Addex Therapeutics Does
Addex Therapeutics is a drug development company focused on medicines that act on G protein-coupled receptors, especially through a method called allosteric modulation. In plain English, it tries to make small-molecule drugs that fine-tune how receptors in the brain and body work, rather than simply switching them on or off. Its main work is centered on treatments for nervous system and inflammatory diseases, where receptor control can affect symptoms and disease pathways.
- Headquarters
- Switzerland CH
- Employees
- 3
- IPO date
- May 22, 2007
Revenue & Expenses Breakdown
Addex Therapeutics Ltd
Earnings Waterfall
Addex Therapeutics Ltd
The intrinsic value for Addex Therapeutics Ltd (APE) under the Base Case is 0.675 EUR.
Compared with the current market price of 2.196 EUR, the stock appears Overvalued by 69% .